Nanotronics raises $30 million for automated microscope tech

Share

NanotronicsNanotronics – which boasts what it says is the world’s most advanced automated microscopes – said today that it has raised $30 million – bringing its total money raised to $71 million.

The Investment Corporation of Dubai (ICD) led the Series D round, with participation from current investor Founders Fund.

The money will accelerate development of Nanotronics’ optical inspection technologies and proprietary industrial enterprise software – as well as an expansion next year into key regions of Asia.

“From the first Nanotronics system sold six years ago, to the over 60 factories we now operate in around the world, we are bringing our mission of delivering a convergence of the most advanced technologies back to industry,” Matthew Putman, Nanotronics’ founder and CEO, said in a news release.

“Our expansion will fuel an engine of invention, and as we enable our customers to deploy better technology, Nanotronics’ methods and opportunities will be further positioned at the center of the global manufacturing network.”

ICD has a diverse investment portfolio, with more than 40 company investments and a presence in more than 50 countries.

“This investment reaffirms ICD’s strategic commitment towards technology innovation and marks the beginning of a long-term partnership with Nanotronics which we believe is playing an important role in shaping the future of advanced manufacturing and inspection across global industries,” said Khalifa Al Daboos, Deputy CEO of ICD.

Nanotronics boasts that its automated microscope such as systems such as nSPEC and nSPEC 3D easily integrate into manufacturing supply chains, providing a powerful tool for everything from MEMs and semiconductors to aerospace hardware, nano-medicine, and DNA sequencing and storage.

(Learn from some of the medical device industry’s top executives and experts at DeviceTalks West, Dec. 11–12 in Orange County, Calif.)

Join us in Southern California this December for DeviceTalks West on 12/11-12/12

textadimage We've attracted a diverse group of thought leaders from some of the Golden State's best medtech companies — including Bigfoot Biomedical, BD, Alphabet's Verily, Integer, Medtronic Neurovascular, Medtronic Diabetes, Smith & Nephew and many more for DeviceTalks West.

Check out our web site for latest news on speakers, agenda and event information.


Get your tickets today! »

Speak Your Mind

*